The CD36 dynamic change after radiation therapy in lung cancer patients and its correlation with symptomatic radiation pneumonitis

Radiotherapy and Oncology

Volumn 107, Issue 3, 2013, Pages 389-391

  Bai, Lu ^b   Zhao, Junhua ^c   Yu, Hong ^d   Zhao, Na ^a   Liu, Dan ^a   Zhong, Wen ^a   Zhao, Yuxia ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b The First Affiliated Hospital of China Medical University   (China)

^c Department of the Seven year Clinics of China Medical University ^*  (China)

^d Liaoning Cancer and Institute   (China)

Author keywords

CD36; Lung cancer; Radiation induced pneumonitis; Radiotherapy

Indexed keywords

CD36 ANTIGEN;

ARTICLE; CANCER RADIOTHERAPY; CASE CONTROL STUDY; CLINICAL ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DAILY LIFE ACTIVITY; HUMAN; KARNOFSKY PERFORMANCE STATUS; LUNG CANCER; LUNG RESECTION; OXYGEN THERAPY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RADIATION PNEUMONIA; RETROSPECTIVE STUDY;

CD36; LUNG CANCER; RADIATION-INDUCED PNEUMONITIS; RADIOTHERAPY;

ANTIGENS, CD36; HUMANS; LUNG NEOPLASMS; RADIATION PNEUMONITIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84881479790     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2013.04.014     Document Type: Article

References (17)

1. H.P. Rodemann Molecular radiation biology: perspectives for radiation oncology Radiother Oncol 92 2009 293 298
2. F.A. Stewart, and W. Dorr Milestones in normal tissue radiation biology over the past 50 years: from clonogenic cell survival to cytokine networks and back to stem cell recovery Int J Radiat Biol 85 2009 574 586
3. M. Machtay Pulmonary complications of anticancer treatment 3rd ed. 2003 Churchill Livingston
4. J.Y. Wang, K.Y. Chen, and J.T. Wang Outcome and prognostic factors for patients with non-small-cell lung cancer and severe radiation pneumonitis Int J Radiat Oncol Biol Phys 54 2002 735 741
5. T.J. Robnett, M. Machtay, and E.F. Vines Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer Int J Radiat Oncol Biol Phys 48 2000 89 94
6. L. Hughes-Davies, N.J. Tarbell, and C.N. Coleman Stage IA-IIB Hodgkin's disease: management and outcome of extensive thoracic involvement Int J Radiat Oncol Biol Phys 39 1997 361 369
7. L.B. Marks, M. Fan, and R. Clough Radiation-induced pulmonary injury: symptomatic versus subclinical endpoints Int J Radiat Biol 76 2000 469 475
8. K.R. Trott, T. Herrmann, and M. Kasper Target cells in radiation pneumopathy Int J Radiat Oncol Biol Phys 58 2004 463 469
9. C.E. Rube, H.P. Rodemann, and C. Rube The relevance of cytokines in the radiation-induced lung reaction. Experimental basis and clinical significance Strahlenther Onkol 180 2004 541 549
10. P.G. Tsoutsou, and M.I. Koukourakis Radiation pneumonitis and fibrosis: mechanisms underlying its pathogenesis and implications for future research Int J Radiat Oncol Biol Phys 66 2006 1281 1293
11. A. Azuma, Y.J. Li, and S. Abe Interferon-β inhibits bleomycin-induced lung fibrosis by decreasing transforming growth factor-β 1 and thrombospondin Am J Respir Cell Mol Biol 32 2005 93 98
12. J.M. Brown, E.J. Swindle, N.M. Kushnir-Sukhov, A. Holian, and D.D. Metcalfe Silica-directed mast cell activation is enhanced by scavenger receptors Am J Respir Cell Mol Biol 36 2007 43 52
13. T. Yehualaeshet, R. O'Connor, and J. Green-Johnson Activation of rat alveolar macrophage-derived latent transforming growth factor-β1 by plasmin requires interaction with thrombospondin-1 and its cell surface receptor, CD36 Am J Pathol 155 1999 841 851
14. R. Hara, J. Itami, and T. Komiyama Serum levels of KL-6 for predicting the occurrence of radiation pneumonitis after stereotactic radiotherapy for lung tumors Chest 125 2004 340 344
15. Hiromitsu Iwata, Yuta Shibamoto, and Fumiya Baba Correlation between the serum KL-6 level and the grade of radiation pneumonitis after stereotactic body radiotherapy for stage I lung cancer or small lung metastasis Radiother Oncol 101 2011 267 270
16. Xin Wang, Ying Chen, and Lina Lv Silencing CD36 gene expression results in the inhibition of latent-TGF-β activation and suppression of silica-induced lung fibrosis in the rat Respir Res 10 2009 36
17. T. Yehualaeshet, R. O'Connor, and A. Begleiter A CD36 synthetic peptide inhibits bleomycin-induced pulmonary inflammation and connective tissue synthesis in the rat Am J Respir Cell Mol Biol 23 2000 204 212